-
ATHA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Athira Pharma (ATHA)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 77.86 mm | 77.86 mm | 77.86 mm | 77.86 mm | 77.86 mm | 77.86 mm |
Cash burn (monthly) | 1.66 mm | 3.03 mm | 9.87 mm | 10.14 mm | 7.67 mm | 6.09 mm |
Cash used (since last report) | 4.65 mm | 8.51 mm | 27.71 mm | 28.46 mm | 21.54 mm | 17.08 mm |
Cash remaining | 73.21 mm | 69.35 mm | 50.15 mm | 49.40 mm | 56.32 mm | 60.78 mm |
Runway (months of cash) | 44.2 | 22.9 | 5.1 | 4.9 | 7.3 | 10.0 |
13F holders | Current |
---|---|
Total holders | 38 |
Opened positions | 13 |
Closed positions | 35 |
Increased positions | 1 |
Reduced positions | 12 |
13F shares | Current |
---|---|
Total value | 36.61 bn |
Total shares | 14.98 mm |
Total puts | 97.80 k |
Total calls | 73.40 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Perceptive Advisors | 5.40 mm | $14.32 bn |
Baker Bros. Advisors | 3.15 mm | $8.36 bn |
Wasatch Advisors | 1.30 mm | $3.43 bn |
Tang Capital Management | 1.05 mm | $2.79 bn |
Venrock Healthcare Capital Partners II | 1.00 mm | $0.00 |
Jacobs Levy Equity Management | 506.82 k | $1.34 bn |
Pathstone | 492.23 k | $1.30 bn |
Two Sigma Advisers | 360.90 k | $956.39 mm |
Two Sigma Investments | 302.13 k | $800.65 mm |
BAC Bank of America | 228.66 k | $605.93 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Oct 24 | Mark James Litton | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4499 | 325,000 | 146.22 k | 325,000 |
3 Oct 24 | Mark James Litton | RSU Common Stock | Grant | Acquire A | No | No | 0 | 325,000 | 0.00 | 325,000 |
3 Oct 24 | Mark James Litton | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4257 | 325,000 | 138.35 k | 325,000 |
1 Oct 24 | Mark Worthington | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4499 | 110,000 | 49.49 k | 110,000 |
1 Oct 24 | Mark Worthington | RSU Common Stock | Grant | Acquire A | No | No | 0 | 110,000 | 0.00 | 110,000 |
1 Oct 24 | Kevin Church | Stock Option Common Stock | Grant | Acquire A | No | No | 0.4499 | 110,000 | 49.49 k | 110,000 |
1 Oct 24 | Kevin Church | RSU Common Stock | Grant | Acquire A | No | No | 0 | 110,000 | 0.00 | 110,000 |